kr577.00
1.12% today
Copenhagen, Nov 20, 05:00 pm CET
ISIN
DK0060448595
Symbol
COLO B

Coloplast A/S B Target price 2025 - Analyst rating & recommendation

Coloplast A/S B Classifications & Recommendation:

Buy
31%
Hold
62%
Sell
8%

Coloplast A/S B Price Target

Target Price kr673.20
Price kr577.00
Potential
Number of Estimates 22
22 Analysts have issued a price target Coloplast A/S B 2026 . The average Coloplast A/S B target price is kr673.20. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 26 analysts: 8 Analysts recommend Coloplast A/S B to buy, 16 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Coloplast A/S B stock has an average upside potential 2026 of . Most analysts recommend the Coloplast A/S B stock at Hold.

Sales and Margin forecast 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '25 2026
Estimates
Revenue Billion kr 27.87 29.88
3.12% 7.20%
EBITDA Margin 30.42% 32.55%
1.89% 7.01%
Net Margin 13.04% 19.51%
30.21% 49.57%

23 Analysts have issued a sales forecast Coloplast A/S B 2026 . The average Coloplast A/S B sales estimate is

kr29.9b
Unlock
. This is
7.20% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
kr31.9b 14.52%
Unlock
, the lowest is
kr28.1b 0.66%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 kr27.9b 3.12%
2026
kr29.9b 7.20%
Unlock
2027
kr32.1b 7.42%
Unlock
2028
kr35.3b 9.94%
Unlock
2029
kr38.0b 7.75%
Unlock
2030
kr40.6b 6.88%
Unlock
2031
kr43.2b 6.22%
Unlock
2032
kr46.2b 7.08%
Unlock

22 Analysts have issued an Coloplast A/S B EBITDA forecast 2026. The average Coloplast A/S B EBITDA estimate is

kr9.7b
Unlock
. This is
6.62% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
kr10.6b 15.94%
Unlock
, the lowest is
kr9.1b 0.11%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 kr8.5b 5.07%
2026
kr9.7b 14.72%
Unlock
2027
kr10.6b 9.21%
Unlock
2028
kr11.8b 11.12%
Unlock
2029
kr12.9b 9.30%
Unlock
2030
kr13.6b 5.29%
Unlock

EBITDA Margin

2025 30.42% 1.89%
2026
32.55% 7.01%
Unlock
2027
33.09% 1.66%
Unlock
2028
33.45% 1.09%
Unlock
2029
33.93% 1.43%
Unlock
2030
33.42% 1.50%
Unlock

23 Coloplast A/S B Analysts have issued a net profit forecast 2026. The average Coloplast A/S B net profit estimate is

kr5.8b
Unlock
. This is
60.38% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
kr6.5b 79.24%
Unlock
, the lowest is
kr5.3b 46.94%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 kr3.6b 28.03%
2026
kr5.8b 60.38%
Unlock
2027
kr6.5b 10.73%
Unlock
2028
kr7.6b 17.05%
Unlock
2029
kr8.4b 10.93%
Unlock
2030
kr8.8b 5.47%
Unlock

Net Margin

2025 13.04% 30.21%
2026
19.51% 49.57%
Unlock
2027
20.12% 3.13%
Unlock
2028
21.42% 6.46%
Unlock
2029
22.05% 2.94%
Unlock
2030
21.76% 1.32%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '25 2026
Estimates
Earnings Per Share kr 16.13 25.87
28.18% 60.38%
P/E 22.05
EV/Sales 5.07

23 Analysts have issued a Coloplast A/S B forecast for earnings per share. The average Coloplast A/S B EPS is

kr25.87
Unlock
. This is
60.38% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
kr28.92 79.29%
Unlock
, the lowest is
kr23.71 46.99%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 kr16.13 28.18%
2026
kr25.87 60.38%
Unlock
2027
kr28.65 10.75%
Unlock
2028
kr33.54 17.07%
Unlock
2029
kr37.20 10.91%
Unlock
2030
kr39.24 5.48%
Unlock

P/E ratio

Current 35.38 12.07%
2026
22.05 37.67%
Unlock
2027
19.91 9.71%
Unlock
2028
17.01 14.57%
Unlock
2029
15.34 9.82%
Unlock
2030
14.54 5.22%
Unlock

Based on analysts' sales estimates for 2026, the Coloplast A/S B stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 5.44 30.43%
2026
5.07 6.74%
Unlock
2027
4.72 6.91%
Unlock
2028
4.30 9.04%
Unlock
2029
3.99 7.19%
Unlock
2030
3.73 6.43%
Unlock
2031
3.51 5.85%
Unlock
2032
3.28 6.61%
Unlock

P/S ratio

Current 4.66 33.50%
2026
4.35 6.72%
Unlock
2027
4.05 6.91%
Unlock
2028
3.68 9.04%
Unlock
2029
3.42 7.19%
Unlock
2030
3.20 6.43%
Unlock
2031
3.01 5.86%
Unlock
2032
2.81 6.62%
Unlock

Current Coloplast A/S B Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
ROTHSCHILD & CO REDBURN
Locked
Locked
Locked Sep 08 2025
BERENBERG
Locked
Locked
Locked Sep 05 2025
EQUITA SIM
Locked
Locked
Locked Sep 03 2025
JEFFERIES
Locked
Locked
Locked Aug 29 2025
HANDELSBANKEN CAPITAL MARKETS
Locked
Locked
Locked Aug 20 2025
JEFFERIES
Locked
Locked
Locked Jul 18 2025
JEFFERIES
Locked
Locked
Locked Jul 17 2025
Analyst Rating Date
Locked
ROTHSCHILD & CO REDBURN:
Locked
Locked
Sep 08 2025
Locked
BERENBERG:
Locked
Locked
Sep 05 2025
Locked
EQUITA SIM:
Locked
Locked
Sep 03 2025
Locked
JEFFERIES:
Locked
Locked
Aug 29 2025
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
Locked
Aug 20 2025
Locked
JEFFERIES:
Locked
Locked
Jul 18 2025
Locked
JEFFERIES:
Locked
Locked
Jul 17 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today